OBJECTIVE: To determine if the Beliefs about Medicines Questionnaire (BMQ) has satisfactory psychometric properties in patients with severe mental disorders and if their scores differ from those of patients with severe medical disorders. To investigate if the scores are related to medication adherence. METHOD: Two hundred and eighty psychiatric patients completed the BMQ and reported how much of their medication they had taken the past week. Serum concentrations of medications were analyzed. BMQ scores were compared with those of patients with chronic medical disorders. RESULTS: Cronbach's alpha was satisfactory for all subscales. The psychiatric group scored lower on the necessity of taking medication than the medical group. Non-adherent patients felt medication to be less necessary and were more concerned about it than adherent patients. The necessity subscale predicted adherence fairly well. CONCLUSION: The BMQ has satisfactory psychometric properties for use in patients with severe mental disorders. The constructs measured by the BMQ are related to adherence in these patients.
OBJECTIVE: To determine if the Beliefs about Medicines Questionnaire (BMQ) has satisfactory psychometric properties in patients with severe mental disorders and if their scores differ from those of patients with severe medical disorders. To investigate if the scores are related to medication adherence. METHOD: Two hundred and eighty psychiatricpatients completed the BMQ and reported how much of their medication they had taken the past week. Serum concentrations of medications were analyzed. BMQ scores were compared with those of patients with chronic medical disorders. RESULTS: Cronbach's alpha was satisfactory for all subscales. The psychiatric group scored lower on the necessity of taking medication than the medical group. Non-adherent patients felt medication to be less necessary and were more concerned about it than adherent patients. The necessity subscale predicted adherence fairly well. CONCLUSION: The BMQ has satisfactory psychometric properties for use in patients with severe mental disorders. The constructs measured by the BMQ are related to adherence in these patients.
Authors: Julie Kreyenbuhl; Jaclyn Leith; Deborah R Medoff; Lijuan Fang; Faith B Dickerson; Clayton H Brown; Richard W Goldberg; Wendy Potts; Lisa B Dixon Journal: Psychiatry Res Date: 2011-04-02 Impact factor: 3.222
Authors: Talitha I Verhoef; W Ken Redekop; Marcel L Bouvy; Brenda Dorenbos; Zamiera Karwar; Rianne M F van Schie; Anthonius de Boer; Anke-Hilse Maitland-van der Zee Journal: Br J Clin Pharmacol Date: 2014-08 Impact factor: 4.335
Authors: Lucie Kalisova; Jiri Raboch; Alexander Nawka; Gaia Sampogna; Libor Cihal; Thomas W Kallert; Georgi Onchev; Anastasia Karastergiou; Valeria Del Vecchio; Andrzej Kiejna; Tomasz Adamowski; Francisco Torres-Gonzales; Jorge A Cervilla; Stephan Priebe; Domenico Giacco; Lars Kjellin; Algirdas Dembinskas; Andrea Fiorillo Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2014-04-16 Impact factor: 4.328
Authors: Nicolas Rüsch; Andrew R Todd; Galen V Bodenhausen; Peter J Weiden; Patrick W Corrigan Journal: Schizophr Res Date: 2009-05-01 Impact factor: 4.939